Evidence map›Paper›PMID 30102652›Full record

Trial reportAIDS (London, England)2018

Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis.

Síle F Molloy, John Bradley, Natasha Karunaharan, Muhammad Mputu, Neil Stone, Jacob Phulusa, Chimwemwe Chawinga, Kate Gaskell, Dalitso Segula, Damien Ming and 7 more

Open access · hybridAbstract readLetterRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. 1-Minute Pearls/Pitfalls for the Clinician.Journal of Brown hospital medicine · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Síle F MolloyCentre for Global Health, Institute for Infection and Immunity, St George's University of London.
John BradleyMRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
Natasha KarunaharanCentre for Global Health, Institute for Infection and Immunity, St George's University of London.
Muhammad MputuUniversity Teaching Hospital, Lusaka, Zambia.
Neil StoneCentre for Global Health, Institute for Infection and Immunity, St George's University of London.
Jacob PhulusaUniversity of North Carolina Project-Malawi, Kamuzu Central Hospital, Lilongwe.
Chimwemwe ChawingaUniversity of North Carolina Project-Malawi, Kamuzu Central Hospital, Lilongwe.
Kate GaskellMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Malawi.
Dalitso SegulaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Malawi.
Damien MingMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Malawi.
Mary PeirseMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Malawi.
Duncan ChandaUniversity Teaching Hospital, Lusaka, Zambia.
Shabir LakhiUniversity Teaching Hospital, Lusaka, Zambia.
Angela LoyseCentre for Global Health, Institute for Infection and Immunity, St George's University of London.
Cecilia KanyamaUniversity of North Carolina Project-Malawi, Kamuzu Central Hospital, Lilongwe.
Robert S HeydermanMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Malawi.
Thomas S HarrisonCentre for Global Health, Institute for Infection and Immunity, St George's University of London.
St George's, University of London · GBKamuzu Central Hospital · MWUniversity of Liverpool · GBUniversity Teaching Hospital · ZMLondon School of Hygiene & Tropical Medicine · GBMalawi-Liverpool-Wellcome Trust Clinical Research Programme · MWUniversity College London · GBUniversity of Zambia · ZM

Funding

Malawi HIV Implementation Research Scientist Training Program (MHIRST)D43TW010060 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MINA CHRISTINE HOSSEINIPOUR, Victor Mwapasa · 2015 to 2026
$3.8M
FIC NIH HHS D43 TW010060Medical Research Council 100504Medical Research Council G1100814Medical Research Council MR/K012126/1
6 · The paper itself

Abstract

: We assessed the effect of fluconazole 1200 mg/day on the QT interval in cryptococcal meningitis patients. Mean corrected QT (QTc) change from baseline to day 7 was 10.1 ms (IQR: -28 to 46 ms) in the fluconazole treatment group and -12.6 ms (IQR: -39 to 13.5 ms) in those not taking fluconazole (P = 0.04). No significant increase in QTc measurements over 500 ms was observed with fluconazole. Nevertheless, it remains important to correct any electrolyte imbalance and avoid concomitant drugs that may increase QTc.

Indexed as

AdultAfricaAntifungal AgentsFluconazoleHeart Conduction SystemHIV InfectionsHumansMeningitis, CryptococcalAntifungal AgentsFluconazole

Identifiers

PMID30102652
PMCPMC6150187
OpenAlexW2885503435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.